Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Carbohydr Polym ; 97(2): 551-7, 2013 Sep 12.
Article in English | MEDLINE | ID: mdl-23911484

ABSTRACT

The aim of the present study was to determine the impact of serial modifications of starch, including firstly starch extrusion or hydrolysis with pullulanase, followed by retrogradation (through freezing and defrosting of pastes) and acetylation (under industrial conditions), on its susceptibility to amylolysis. The method of production had a significant effect on properties of the resultant preparations, whilst the direction and extent of changes depended on the type of modification applied. In the produced starch esters, the degree of substitution, expressed by the per cent of acetylation, ranged from 3.1 to 4.4 g/100 g. The acetylation had a significant impact on contents of elements determined with the atomic emission spectrometry, as it contributed to an increased Na content and decreased contents of Ca and K. The DSC thermal characteristics enabled concluding that the modifications caused an increase in temperatures and a decrease in heat of transition (or its lack). The acetylation of retrograded starch preparations increased their solubility in water and water absorbability. The modifications were found to exert various effects on the rheological properties of pastes determined based on the Brabender's pasting characteristics and flow curves determined with the use of an oscillatory-rotating viscosimeter. All starch acetates produced were characterized by ca. 40% resistance to amylolysis.


Subject(s)
Glycoside Hydrolases/metabolism , Starch/analogs & derivatives , Absorption , Acetylation , Calorimetry, Differential Scanning , Glucan 1,4-alpha-Glucosidase/metabolism , Hydrolysis , Phase Transition , Solanum tuberosum/chemistry , Solubility , Starch/metabolism , Viscosity , Water/chemistry
2.
Dement Geriatr Cogn Disord ; 31(6): 417-23, 2011.
Article in English | MEDLINE | ID: mdl-21757906

ABSTRACT

BACKGROUND: The relationship between different paraoxonase (PON) gene polymorphisms and the risk of Alzheimer's disease (AD) was studied several times and the results were controversial. METHODS: We investigated the association of 4 single-nucleotide polymorphisms (SNPs) of the PON1 (M55L; Q192R; -161C/T) and the PON2 (C311S) genes that were shown to affect the risk of sporadic AD. We studied 360 Caucasian cases with late-onset AD and 354 nondemented controls. RESULTS: No significant differences were observed between the studied PON SNPs and AD risk. The results did not change after stratification of the apolipoprotein E status. Meta-analyses of studies in Caucasians assessing the associations between the PON1 M55L, -161C/T and Q192R SNPs and the risk of AD were performed, and no associations were found. CONCLUSION: Our results suggest that the studied PON1 and PON2 polymorphisms are not associated with late-onset AD.


Subject(s)
Alzheimer Disease/epidemiology , Alzheimer Disease/genetics , Aryldialkylphosphatase/genetics , Polymorphism, Genetic/genetics , Age Factors , Age of Onset , Aged , Alleles , Apolipoproteins E/genetics , DNA/genetics , Female , Gene Frequency , Genotype , Haplotypes , Humans , Linkage Disequilibrium , Male , Poland/epidemiology , Polymorphism, Single Nucleotide , Population , Real-Time Polymerase Chain Reaction , Regression Analysis , Risk Factors , Sex Factors
3.
Neurodegener Dis ; 7(1-3): 143-7, 2010.
Article in English | MEDLINE | ID: mdl-20197694

ABSTRACT

In this study, we demonstrated for the first time an increased CD44 gene expression in lymphocytes derived from Alzheimer's disease (AD) patients in comparison with healthy subjects. CD44 is a surface antigen expressed by cells of the immune and central nervous system as well as in a variety of other tissues. Functioning as adhesion molecule, CD44 is furthermore involved in driving immune response into infected tissues, including the CNS. We also found that lymphocytes of the same patients expressed significant levels of unfolded p53 isoform, confirming what we already demonstrated in fibroblasts and lymphocytes derived from other cohorts of AD patients. A correlation between p53 and CD44 expression has been well demonstrated in cancer cells, suggesting that CD44 could be a target gene of mutant p53, or either mutant p53 could lack its ability to negatively regulate CD44 expression. The contemporaneous increased expression of unfolded p53 and CD44 in AD lymphocytes may suggest that these two molecules cross-talk together participating in peripheral immune response during the development of the disease.


Subject(s)
Alzheimer Disease/pathology , Gene Expression Regulation/physiology , Hyaluronan Receptors/metabolism , Lymphocytes/metabolism , Aged , Aged, 80 and over , Female , Humans , Hyaluronan Receptors/genetics , Male , Middle Aged
4.
Dement Geriatr Cogn Disord ; 28(5): 461-4, 2009.
Article in English | MEDLINE | ID: mdl-19940477

ABSTRACT

Interleukin-1 is a potent proinflammatory cytokine involved in the pathophysiology of Alzheimer's disease (AD). We genotyped IL-1beta (-511 C/T) and the apolipoprotein E (APOE) common polymorphisms in a large case-controlled study in a Polish population. We included 332 patients with late-onset AD and 220 controls without any neurological deficit, cognitive complaints and history of neurological diseases, aged > or = 65 years. The distribution of the IL-1beta (-511 C/T) genotypes was similar to that in the controls (AD: C/C = 45.8%, C/T = 44.6%, T/T = 9.6% vs. controls: C/C = 53.9%, C/T = 38.3%, T/T = 7.3%, p > 0.05). Our study confirms previous reports that APOE epsilon4 is strongly related to the risk of AD (odds ratio = 6.60, 95% confidence interval 4.19-10.41). APOE status did not affect the distribution of the studied IL-1beta polymorphism. The IL-1beta (-511 C/T) polymorphism is not a risk factor for late-onset AD in a Polish population.


Subject(s)
Alzheimer Disease/epidemiology , Alzheimer Disease/genetics , Interleukin-1beta/genetics , Polymorphism, Genetic , Age of Onset , Aged , Aged, 80 and over , Apolipoprotein E4/genetics , Case-Control Studies , Female , Genetic Predisposition to Disease/epidemiology , Genotype , Humans , Male , Poland/epidemiology , Risk Factors
5.
J Neural Transm (Vienna) ; 115(1): 85-90, 2008.
Article in English | MEDLINE | ID: mdl-18087668

ABSTRACT

Presenilin 2 gene (PSEN2) is one of the causative genes for familial Alzheimer's disease. A delA polymorphism located in PSEN2 promoter was proposed to be a risk factor for early-onset AD. We examined association between AD and PSEN2 polymorphisms located in two 5'UTR regions in group of 217 late-onset AD patients, 109 mild cognitive impairment patients, and 225 non-demented control subjects. No significant differences for genotype and allele distributions of a delA and a novel insAC polymorphisms in the studied groups as compared to controls were observed. Univariate and multivariate risk estimation shows that neither delA, insAC alleles nor the genotypes are risk factors for AD. No significant interaction between the APOE4 and PSEN2 polymorphisms was found. A bioinformatic analysis showed that delA polymorphism influences binding sites of transcription factors involved in the cellular processes related to AD. The rare variants identified in exon 3 of the PSEN2 could have a potential influence on PSEN2 transcript splicing.


Subject(s)
Alzheimer Disease/genetics , Genetic Predisposition to Disease , Polymorphism, Genetic , Presenilin-2/genetics , Alternative Splicing , Gene Frequency , Genotype , Humans , Poland , Promoter Regions, Genetic , Risk Factors
6.
Mol Psychiatry ; 13(6): 641-7, 2008 Jun.
Article in English | MEDLINE | ID: mdl-17684496

ABSTRACT

The identification of biological markers of Alzheimer's disease (AD) can be extremely useful to improve diagnostic accuracy and/or to monitor the efficacy of putative therapies. In this regard, peripheral cells may be of great importance, because of their easy accessibility. After subjects were grouped according to diagnosis, the expression of conformationally mutant p53 in blood cells was compared by immunoprecipitation or by a cytofluorimetric assay. In total, 104 patients with AD, 92 age-matched controls, 15 patients with Parkinson's disease and 9 with other types of dementia were analyzed. Two independent methods to evaluate the differential expression of a conformational mutant p53 were developed. Mononuclear cells were analyzed by immunoprecipitation or by flow-cytometric analysis, following incubation with a conformation-specific p53 antibody, which discriminates unfolded p53 tertiary structure. Mononuclear cells from AD patients express a higher amount of mutant-like p53 compared to non-AD subjects, thus supporting the study of conformational mutant p53 as a new putative marker to discriminate AD from non-AD patients. We also observed a strong positive correlation between the expression of p53 and the age of patients. The expression of p53 was independent from the length of illness and from the Mini Mental State Examination value.


Subject(s)
Alzheimer Disease/genetics , Tumor Suppressor Protein p53/chemistry , Tumor Suppressor Protein p53/genetics , Aged , Aged, 80 and over , Aging/genetics , DNA/blood , DNA/genetics , DNA/isolation & purification , Dementia/blood , Dementia/genetics , Flow Cytometry , Humans , Italy , Leukocytes , Parkinson Disease/blood , Parkinson Disease/genetics , Poland , Protein Conformation , Reference Values , Tumor Suppressor Protein p53/blood
7.
Exp Neurol ; 208(2): 264-8, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17931627

ABSTRACT

A 32-year-old woman diagnosed with very rapidly progressing early-onset Alzheimer's disease (EOAD), age of onset 29 years, and S170F mutation in presenilin 1 gene (PSEN1) is presented. Neuroimaging conducted 2 years after the first symptoms was typical for the advanced stage of Alzheimer's disease (AD), showing cortical brain atrophy, particularly within hippocampus, frontal and temporal cortex. The unaffected parents of the proband are not carriers of the mutation. The paternity was confirmed by microsatellite typing, strongly suggesting de novo origin of S170F mutation. In silico modeling of S170F mutation impact on presenilin 1 (PS1) transmembrane structure indicates that the mutation considerably alters putative interactions of PS1 with other proteins within gamma-secretase complex.


Subject(s)
Alzheimer Disease/genetics , Mutation , Presenilin-1/genetics , Adult , Alzheimer Disease/diagnosis , Brain/pathology , Disease Progression , Female , Humans , Magnetic Resonance Imaging , Models, Molecular , Phenylalanine , Serine , Time Factors
8.
Int J Geriatr Psychiatry ; 22(10): 1004-8, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17431928

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate the cognitive state of highly selected Polish centenarians and analyze the mechanisms of their functioning. METHODS: The selected centenarian group (10 persons) and a reference group (20 persons) who started aging (65 years) were examined with a sensitive set of neuropsychological tests and tasks in clinical-experimental assessment. RESULTS: As expected, the centenarians' cognitive functions were different from those of the subjects who started aging, however, not in all aspects. For instance, the former scored significantly lower in the area of linguistic functions but the ability to plan and controlled perform complex visuospatial task with use of simultaneous and sequential strategies was preserved despite unfavorable symptoms of natural aging such as permanence attention as well as prolonged action time. CONCLUSIONS: The results suggest that the studied centenarians show a dominant right-hemispheric pattern functioning not only in relation to perception, but also to planning and executing complex activities. The study and description of preserved neurocognition of centenarians was possible due to introducing a special procedure sensitive to the preserved functions.


Subject(s)
Aging/physiology , Cognition/physiology , Aged , Aged, 80 and over , Female , Geriatric Assessment/methods , Humans , Male , Middle Aged , Neuropsychological Tests , Poland
9.
Int J Geriatr Psychiatry ; 22(6): 563-7, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17136705

ABSTRACT

BACKGROUND: Mild cognitive impairment (MCI) is a condition referring to the persons with cognitive deficits measurable in some form or another, but not meeting criteria for dementia, and who have an increased risk of becoming demented. OBJECTIVE: To establish the rate of progression to dementia in MCI, to investigate the risk of conversion for amnestic vs multiple-domains subtypes, and to identify the predictors of progression. METHODS: MCI (n = 105) individuals enrolled in a longitudinal study received annual clinical and psychometric examinations for up to a mean of 3 years. The diagnosis of MCI according to Mayo Clinic Petersen's Criteria was conducted by a panel of specialists. RESULTS: After 3 years of follow-up, 23 of 105 subjects with MCI were diagnosed with dementia. 40 showed cognitive decline not dementia, 34 were stable and showed no cognitive decline or improvement, while eight showed cognitive improvement. CONCLUSIONS: We conclude that conversion rate from MCI to DSM-IIIR dementia was 21.9% over a period of 3 years. The occurrence of depressive symptoms may constitute a predictor for those who are more likely to progress to dementia. The risk of conversion to dementia was higher among the subjects with an evidence of impairment extending beyond memory than with those who suffered only from memory deficits, and the subjects who converted to dementia in this subtype had significantly higher baseline plasma total homocysteine levels than non-converters.


Subject(s)
Alzheimer Disease/epidemiology , Cognition Disorders/epidemiology , Depressive Disorder/epidemiology , Aged , Alzheimer Disease/diagnosis , Alzheimer Disease/psychology , Cognition Disorders/diagnosis , Cognition Disorders/psychology , Comorbidity , Cross-Sectional Studies , Depressive Disorder/diagnosis , Depressive Disorder/psychology , Disease Progression , Female , Follow-Up Studies , Humans , Male , Mental Status Schedule , Middle Aged , Poland , Risk Factors
10.
J Neural Transm (Vienna) ; 113(11): 1747-51, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16897605

ABSTRACT

Prion protein gene polymorphism M129V represents a known risk factor for Creutzfeldt-Jakob disease. Recently, the meta-analysis revealed that homozygosity at codon 129 is connected with increased risk of Alzheimer's disease (AD). To determine whether M129V polymorphism is a risk factor for AD we analyzed a group of early-onset, and late-onset Polish AD patients. We observed that in LOAD patients there is a statistically significant increase of MM (p=0.0028) and decrease of MV (p=0.0006) genotype frequency, as compared to controls. When both groups were stratified according to APOE4 status, increase of MM and decrease of MV genotype frequency were significant in the LOAD subgroup with no APOE4 (p=0.017, and p=0.018, respectively). In the subgroup with APOE4 allele, only MV genotype frequency was significantly lower, as compared to controls (p=0.035). However, no interaction was found between APOE4 status and M129V polymorphism. We conclude that MM genotype increases LOAD risk in Polish population independently from the APOE4 status.


Subject(s)
Alleles , Alzheimer Disease/genetics , Genetic Predisposition to Disease , Prions/genetics , Age of Onset , Aged , Apolipoprotein E4/genetics , Female , Genotype , Humans , Male , Middle Aged , Poland , Polymorphism, Single-Stranded Conformational , Risk Factors
11.
Neurosci Lett ; 404(1-2): 56-60, 2006 Aug 14.
Article in English | MEDLINE | ID: mdl-16787708

ABSTRACT

Elevated levels of homocysteine have been observed in Parkinson's disease (PD) patients treated with levodopa. However, it is not studied if duration of PD or PD per se is associated with hyperhomocysteinemia. In the present study, the levels of homocysteine in 99 levodopa-treated PD patients, 15 untreated PD patients and 100 controls were examined. We focused on the influence of levodopa dose, duration of therapy and disease as well as genetic (C677T methylenetetrahydrofolate reductase (MTHFR) polymorphism) and environmental factors. We found that levodopa-treated PD patients had elevated homocysteine plasma levels as compared to controls (p < 0.05), but the levels did not depend on levodopa doses. Another factor influencing homocysteine level was the duration of PD (p < 0.001). The frequency of allele C677T of MTHFR gene did not differ between PD and controls. In conclusion, hyperhomocysteinemia is associated with the duration of PD and levodopa treatment and possibly also with PD per se.


Subject(s)
Hyperhomocysteinemia/etiology , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Parkinson Disease/blood , Parkinson Disease/genetics , Polymorphism, Single Nucleotide , Adult , Aged , Aged, 80 and over , Folic Acid , Homocysteine/blood , Humans , Levodopa/therapeutic use , Middle Aged , Parkinson Disease/drug therapy , Reference Values , Vitamin B 12/blood
12.
J Neural Transm (Vienna) ; 112(6): 839-45, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15480851

ABSTRACT

The -22c/t polymorphism in the promoter of the presenilin 1 gene is associated with increased risk for Alzheimer's disease (AD) in some populations. It was shown that -22c allele is connected with two-fold decrease in promoter activity. We studied the impact of the polymorphism in groups of Polish late-onset and early-onset AD patients. Our results suggest that -22c/t polymorphism is not connected with AD in Polish population. The -22t allele showed a high degree of linkage disequilibrium with -2797 insertion of 13 bp. An additional -2923g/t polymorphism is also not connected with -22c/t and is not a risk factor for AD.


Subject(s)
Alzheimer Disease/genetics , Genetic Predisposition to Disease , Membrane Proteins/genetics , Age of Onset , Aged , Chromatography, High Pressure Liquid , Female , Humans , Male , Middle Aged , Poland/epidemiology , Polymorphism, Genetic , Polymorphism, Single-Stranded Conformational , Presenilin-1 , Promoter Regions, Genetic
13.
Int J Geriatr Psychiatry ; 19(12): 1168-72, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15526303

ABSTRACT

OBJECTIVE: The aim of the study was to detect the prevalence of depressive syndromes and symptoms in the sample of elderly persons with Mild Cognitive Impairment (MCI), and to analyse Montgomery-Asberg Depression Rating (MADRS) item scores. METHOD: The subjects of the study were 102 consecutive out-patients with MCI. All subjects were assessed by an experienced psychiatrist and MADRS was applied. Major and minor depressive episodes were defined according to DSM-IV criteria. Factor analysis was used to analyse baseline MADRS item scores. RESULTS: Three patient groups emerged according to the depressive symptoms distribution and severity scores basis: those with major depression constituted 19.6% (n = 20), with minor depression 26.5% (n = 27), and with very few depressive symptoms 53.9% (n = 55). Three interpretable MADRS factors were identified, using the factor analysis with Varimax rotation: the first consisting of apparent and reported sadness, inability to feel, pessimistic thoughts, the second consisting of inner tension, reduced sleep, reduced appetite, suicidal thoughts, and the third with concentration difficulties and lassitude. CONCLUSIONS: It was concluded that both major and minor depression is common in MCI. Three MADRS factors were identified and labelled as anhedonia-pessimism, anxiety-vegetative, and cognitive-inhibition.


Subject(s)
Cognition Disorders/psychology , Depression/diagnosis , Depressive Disorder/diagnosis , Aged , Attitude to Death , Cognition , Depression/psychology , Depressive Disorder/psychology , Female , Humans , Male , Psychiatric Status Rating Scales , Risk Factors , Stress, Psychological
14.
Mult Scler ; 10(3): 266-71, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15222689

ABSTRACT

The importance of apolipoprotein E (ApoE) and myeloperoxidase (MPO) genotypes in the clinical characteristics of multiple sclerosis (MS) has been recently emphasized. In a large group of Polish patients we have tested the hypothesis that polymorphism in ApoE and MPO genes may influence the course of the disease. Genotypes were determined in 117 MS patients (74 females and 43 males; 99 sporadic and 18 familial cases) with mean EDSS of 3.6, mean age of 44. 1 years, mean duration of the disease 12.8 years and mean onset of MS at 31.2 years, and in 100 healthy controls. The relationship between ApoE and MPO genes' polymorphism and the MS activity as well as the defect of remyelination (diffuse demyelination) and brain atrophy on MRI were analysed. The ApoE epsilon4 allele was not related to the disease course or the ApoE epsilon2 to the intensity of demyelination on MRI. The genotype MPO G/G was found in all familial MS and in 57% (56/99) of sporadic cases. This genotype was also related to more pronounced brain atrophy on MRI. The MPO G/G subpopulation was characterized by a significantly higher proportion of patients with secondary progressive MS (P < 0.05) and by a higher value of EDSS. According to our results the MPO G allele is frequently found (in 96% of cases) among Polish patients with MS. More severe nervous tissue damage in the MPO G/G form can be explained by the mechanism of accelerated oxidative stress. It seems that MPO G/G genotype may be one of the genetic factors influencing the progression rate of disability in MS patients.


Subject(s)
Apolipoproteins E/genetics , Multiple Sclerosis/genetics , Multiple Sclerosis/pathology , Peroxidase/genetics , Adolescent , Adult , Aged , Apolipoprotein E2 , Apolipoprotein E4 , Atrophy , Brain/pathology , Family Health , Female , Gene Frequency , Genotype , Humans , Male , Middle Aged , Polymorphism, Genetic
15.
Neurology ; 62(2): 313-5, 2004 Jan 27.
Article in English | MEDLINE | ID: mdl-14745079

ABSTRACT

The authors present a study on the association of PRNP and PRND gene polymorphisms with the occurrence and age at onset of Alzheimer's disease (AD). DNA from 79 Polish patients with probable AD and 107 healthy control subjects was studied. The PRNP codon 129 homozygosity seemed to be associated with the occurrence of AD: In AD patients, the percentage of Val/Val and Met/Met genotypes was higher than in the control subjects. A significant difference appeared also between early-onset (<70 years) and late-onset (> or = 70 years) AD patients in the PRND genotypes.


Subject(s)
Alzheimer Disease/genetics , Amyloid/genetics , Polymorphism, Genetic , Prions/genetics , Protein Precursors/genetics , Age of Onset , Aged , Alzheimer Disease/epidemiology , Apolipoproteins E/genetics , Codon/genetics , DNA Mutational Analysis , GPI-Linked Proteins , Gene Frequency , Genetic Predisposition to Disease , Genotype , Humans , Poland , Prion Proteins
16.
Dement Geriatr Cogn Disord ; 16(2): 64-70, 2003.
Article in English | MEDLINE | ID: mdl-12784029

ABSTRACT

BACKGROUND: Alzheimer's disease (AD) is the most common dementia disorder in elderly people. Currently, the only known genetic factor associated with the development of sporadic AD is the apolipoprotein E (ApoE) 4 allele. There is a need to identify other environmental and genetic risk factors that could modulate the risk of developing sporadic AD. OBJECTIVE: To analyse the correlation between the ApoE and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and plasma homocysteine levels and vitamins (B(12) and folic acid) concentrations in serum from patients with AD and mild cognitive impairment (MCI) as compared with control group. METHODS: The study was carried out in 99 AD patients, 98 subjects with MCI and 100 healthy subjects. Diagnosis of probable AD was made according to the NINCDS-ADRDA and DSM-IV criteria. The following factors were analysed: age, gender, duration of disease, concentration of plasma total homocysteine, folic acid and vitamin B(12) in the serum and the polymorphism of MTHRF and ApoE genes. The results obtained were analysed by multivariate analysis of regression. RESULTS: We found that plasma total homocysteine is increased in AD patients (p < 0.0001) and depended on the MTHFR T/T genotype in the presence of low folate levels (p < 0.05). The increased frequency of ApoE4 allele in the AD population was independent of homocysteine, folic acid and vitamin B(12) levels and MTHFR status. CONCLUSIONS: We conclude that the concentration of plasma total homocysteine is increased in AD patients. This may be associated with the T/T genotype in the MTHFR gene; however, the distribution of the MTHRF C677T polymorphism in the Polish population does not differ in AD and controls.


Subject(s)
Alzheimer Disease/blood , Apolipoproteins E/genetics , Cognition Disorders/blood , Folic Acid/blood , Homocysteine/blood , Oxidoreductases Acting on CH-NH Group Donors/blood , Oxidoreductases Acting on CH-NH Group Donors/genetics , Vitamin B 12/blood , Aged , Alzheimer Disease/enzymology , Alzheimer Disease/genetics , Apolipoproteins E/blood , Cognition Disorders/enzymology , Cognition Disorders/genetics , Humans , Methylenetetrahydrofolate Reductase (NADPH2) , Polymorphism, Genetic
17.
Dement Geriatr Cogn Disord ; 14(4): 208-12, 2002.
Article in English | MEDLINE | ID: mdl-12411763

ABSTRACT

The aim of this study was to define the co-occurrence of behavioural symptoms and Alzheimer's disease (AD) in relation to apolipoprotein E (APOE) genotype. Probable AD patients from the Alzheimer's Day Clinic (n = 139) were assessed with the 'Behavioural Pathology in Alzheimer's Disease' rating scale, and their APOE genotype was determined. This study demonstrated no relationship between presence of the APOE epsilon4 allele and any of the behavioural symptoms assessed, including delusions, hallucinations, depression, activity disturbances, aggressiveness and anxiety. Activity disturbances, delusions, hallucinations and aggressiveness paralleled the severity of AD, increasing in frequency with the severity of the dementia. The prevalence of delusions, hallucinations, aggressiveness and depression were found to be associated with lower levels of education.


Subject(s)
Alzheimer Disease/genetics , Alzheimer Disease/psychology , Aged , Aged, 80 and over , Alzheimer Disease/complications , Apolipoprotein E2 , Apolipoprotein E4 , Apolipoproteins E/genetics , Behavioral Symptoms/diagnosis , Behavioral Symptoms/etiology , Educational Status , Female , Genotype , Humans , Male , Middle Aged , Psychiatric Status Rating Scales , Sampling Studies
18.
Neurol Neurochir Pol ; 35(3): 405-13, 2001.
Article in Polish | MEDLINE | ID: mdl-11732264

ABSTRACT

UNLABELLED: In recent years evidence is increasing that vascular disease is associated with cognitive impairment and dementia. Moreover, presence of cerebrovascular disease may intensify the clinical symptoms of Alzheimer's disease (AD). The aim of the study was to determine the prevalence of vascular risk factors in age and sex matched patients with dementia. We studied 109 patients with AD and 37 patients vascular dementia (VD). DSM-III-R test for dementia, NINCDS-ADRDA guidelines for AD and NINDS-ARIEN for VD were applied. RESULTS: Mean age of dementia onset in AD and VD was 65.8 SD 7.8 and 67.4 SD 7.0 years (p > 0.05), the duration of dementia, MMS and GDS for patients with AD and VD was not significantly different. Arterial hypertension was associated in 51.3% VD and 30.3% AD (p < 0.05), hypotension in 11.1 and 23.6% respectively (p > 0.05), atrial fibrillation was similar in AD and VD, coronary artery disease was presents 64.8% AD and 46.8 VD (p > 0.05) and type 2 diabetes in 21.6% and 10.1% (p > 0.05) respectively. No significant differences in serum lipid profile were found in both groups, except two times higher incidence of normal HDL-cholesterol concentration in AD compare to VD. The relation between alcohol consumption, cigarette smoking and head trauma was similar in both types of dementia. CONCLUSION: Vascular disease and AD have to some extent a shared aetiology, and risk factors that they have in common increase the risk of both disorders independently and vascular disease is perhaps involved in the aetiology of AD.


Subject(s)
Alzheimer Disease/etiology , Cerebrovascular Disorders/complications , Coronary Artery Disease/complications , Dementia, Vascular/etiology , Adult , Aged , Aged, 80 and over , Alzheimer Disease/epidemiology , Alzheimer Disease/psychology , Arrhythmias, Cardiac/complications , Arrhythmias, Cardiac/diagnosis , Arrhythmias, Cardiac/epidemiology , Atrial Fibrillation/complications , Atrial Fibrillation/diagnosis , Atrial Fibrillation/epidemiology , Cerebrovascular Disorders/diagnosis , Cerebrovascular Disorders/epidemiology , Cholesterol/blood , Coronary Artery Disease/diagnosis , Coronary Artery Disease/epidemiology , Dementia, Vascular/epidemiology , Dementia, Vascular/psychology , Depressive Disorder, Major/epidemiology , Depressive Disorder, Major/etiology , Diabetes Mellitus, Type 2/complications , Female , Humans , Hypertension/complications , Hypertension/diagnosis , Hypotension/complications , Hypotension/diagnosis , Male , Middle Aged , Risk Factors
19.
Psychiatr Pol ; 35(1): 93-107, 2001.
Article in Polish | MEDLINE | ID: mdl-11324386

ABSTRACT

The aim of the study was: 1) to estimate the occurrence and intensity of some psychopathological symptoms in the course of Alzheimer's disease, and 2) to examine whether the occurrence of behavioral and psychological symptoms increases with the deepening of dementia process among persons with Alzheimer's disease living in their homes with outpatient treatment. The study was conducted among 94 persons (38 men and 56 women ageing from 52 to 86 years (x = 72.4 +/- 6.9), with education: from 2 to 17 years (x = 11.2 +/- 3.7). Three subgroups were selected for study with regard to the intensity of dementia process, estimated according to Clinical Dementia Rating (CDR): very mild (n = 16, x = 71.4 +/- 6.7), mild (n = 43, x = 72.6 +/- 7.9), moderate (n = 35, x = 72.5 +/- 6.9). Subjects in group II and III fulfill diagnostic criteria of dementia according to ICD-10, DSM IV and criteria of probable AD according to NINCDS-ADRDA. In the estimation of occurrence of behavioral and psychological disturbances: Alzheimer's Disease Assessment Scale--non-cognitive behavior (ADAS-non-cog) and subscale "Change in Personality, Interests, Drive" of Blessed Dementia Scale were used. The results have shown that with the progress of dementia process, the occurrence of the following psychopathological symptoms such as: hallucinations, intensive motor activity, purposeless hyperactivity, pacing, rigidity increases and there is a relinquishment of hobbies. In addition, regardless of the stage of dementia, such behaviors as: apathy, depression, tearfullness, impaired emotional control and disturbances of appetite were observed relatively frequently.


Subject(s)
Alzheimer Disease/epidemiology , Mental Disorders/epidemiology , Age Distribution , Aged , Aged, 80 and over , Alzheimer Disease/classification , Ambulatory Care/statistics & numerical data , Comorbidity , Disease Progression , Female , Humans , Male , Middle Aged , Poland/epidemiology , Sex Distribution
20.
Neurol Neurochir Pol ; 35(6): 1021-33, 2001.
Article in Polish | MEDLINE | ID: mdl-11987699

ABSTRACT

The aim of this study was to test the possible relationship between patterns of cognitive deficits--especially impairment of memory processes--and ApoE genotype in patients with AD. Fifty seven right-handed subjects (31 males and 26 females) were tested in this study. The age of subjects ranged from 50 to 79, the education lasted from 11 to 16 years. All subjects were diagnosed as probable AD patients on the basis of DSM IV and NINCDS-ADRDA criteria. Each subject was examined for: 1) ApoE genotype, 2) general level of activity (GDS and MMSE), 3) neuropsychological evaluation of cognitive processes, using full test battery. 37 patients had at least one of ApoE epsilon 4 allele (e2/4, 3 and 4/4) and 20 patients had none of ApoE 4 allele (e 2/3 and 3/3). The group of tested subjects were subdivided into 2 groups. The first group was comprised by 31 patients with 3-rd stage (according to GDS) of mental activity. Twenty six patients with 4-th stage were included into the second group. Those subgroups did not significantly differ if age, education, gender or ApoE allele were considered. Experimental data were normalized and then analyzed using a statistical package SPSS/PC+. The analysis of variance showed that the type of test, stage of disease and two-way interaction ApoE x type of test were highly significant (P < 0.0001). Some results were obvious and not surprising (e.g. that results of patients with 4-th stage were much worse than the results of patients with stage 3-rd). It turned out that the best results were obtained by our patients in naming tests, the worst--in learning test with distraction. Patients with ApoE epsilon 4 performed better than patients with none ApoE epsilon 4 in the Rey's test, in the similarity test and in the test which required repeating numbers starting from the last one. The differences between the subgroups of patients with different ApoE alleles were confirmed by different distributions of correlations. All statistical analyses were repeated for more homogenous group of patients (only with stage 3-rd). The pattern of results resembled the previous one (i.e. better performance in the same tests) with one exception: additionally, in delayed recall test patients with none ApoE epsilon 4 performed much better that ApoE epsilon 4. Our results showed that some cognitive processes depended on ApoE genotype. Patients with none ApoE epsilon 4 genotype had less severe deficits in delayed recall of new information. On the other hand, working memory appeared to be less affected in patients with ApoE epsilon 4 genotype. Independent of genotype, both group showed similar impairment of learning ability without deficits in remote memory.


Subject(s)
Alzheimer Disease/genetics , Apolipoproteins E/genetics , Cognition Disorders/genetics , Memory Disorders/genetics , Aged , Alzheimer Disease/psychology , Female , Genotype , Humans , Male , Middle Aged , Multivariate Analysis , Neuropsychological Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...